273 related articles for article (PubMed ID: 20589319)
1. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
2. A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.
Margaglione M; Vecchione G; Santacroce R; D'Angelo F; Casetta B; Papa ML; Grandone E; Di Minno G
Thromb Haemost; 2001 Dec; 86(6):1483-8. PubMed ID: 11776317
[TBL] [Abstract][Full Text] [Related]
3. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A.
Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N
Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696
[TBL] [Abstract][Full Text] [Related]
4. Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II.
Soya K; Takezawa Y; Okumura N; Terasawa F
Thromb Res; 2013 Oct; 132(4):465-70. PubMed ID: 24011387
[TBL] [Abstract][Full Text] [Related]
5. In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A>G causing abnormal RNA splicing.
Terasawa F; Kamijyo Y; Fujihara N; Yamauchi K; Kumagai T; Honda T; Shigematsu S; Okumura N
Clin Chim Acta; 2010 Sep; 411(17-18):1325-9. PubMed ID: 20580695
[TBL] [Abstract][Full Text] [Related]
6. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
[TBL] [Abstract][Full Text] [Related]
7. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N
Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
[TBL] [Abstract][Full Text] [Related]
8. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families.
Meyer M; Bergmann F; Brennan SO
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083
[TBL] [Abstract][Full Text] [Related]
9. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL
Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
11. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations.
Castaman G; Giacomelli SH; Duga S; Rodeghiero F
Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984
[No Abstract] [Full Text] [Related]
12. A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.
Xu X; Wu J; Zhai Z; Zhou R; Wang X; Wang H; Ding K; Sun Z; Ni H
Thromb Haemost; 2006 Jun; 95(6):931-5. PubMed ID: 16732370
[TBL] [Abstract][Full Text] [Related]
13. Recombinant variant fibrinogens substituted at residues gamma326Cys and gamma339Cys demonstrated markedly impaired secretion of assembled fibrinogen.
Haneishi A; Terasawa F; Fujihara N; Yamauchi K; Okumura N; Katsuyama T
Thromb Res; 2009 Jul; 124(3):368-72. PubMed ID: 19419756
[TBL] [Abstract][Full Text] [Related]
14. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.
Vorjohann S; Fish RJ; Biron-Andréani C; Nagaswami C; Weisel JW; Boulot P; Reyftmann L; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2010 Nov; 104(5):990-7. PubMed ID: 20806111
[TBL] [Abstract][Full Text] [Related]
15. A novel fibrinogen variant--Liberec: dysfibrinogenaemia associated with gamma Tyr262Cys substitution.
Kotlín R; Sobotková A; Suttnar J; Salaj P; Walterová L; Riedel T; Reicheltová Z; Dyr JE
Eur J Haematol; 2008 Aug; 81(2):123-9. PubMed ID: 18485115
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
17. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain.
Brennan SO; Wyatt JM; May S; De Caigney S; George PM
Thromb Haemost; 2001 Mar; 85(3):450-3. PubMed ID: 11307813
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
19. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.
Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309
[TBL] [Abstract][Full Text] [Related]
20. [Role of fibrinogen Bbeta-chain D-region 454-458 residues for assembly and secretion of intact fibrinogen].
Terasawa F; Takezawa Y; Hirota-Kawadobora M; Okumura N
Rinsho Byori; 2011 Aug; 59(8):741-8. PubMed ID: 21942083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
